$AMRZ

Amrize slides nearly 7% as cost inflation drives weaker-than-expected guidance

Amrize AG (NYSE:AMRZ) reported Q3 earnings of $1.05 per share, beating estimates, but revenue of $3.77B missed expectations. Full-year guidance was lowered, citing cost inflation, sending shares down 6.9%. The company completed an acquisition and returned $1.1B to shareholders.

Original reporting
Published Oct 28, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AMRZ
Bearish
high confidence
Mentioned
$AMRZ
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMRZBearishHigh
01

Why it matters

The lower-than-expected revenue guidance reflects ongoing oil‑price driven cost inflation, prompting a near‑7% share decline.

02

Market read

The earnings and guidance miss are the primary catalyst for the stock's move, making the article highly relevant for traders.

03

What to watch

The $73M cost‑savings from the ASPIRE program and share buyback completion could support longer‑term valuation.

Relevance 8/10Novelty 9/10Timing: today

Background

Amrize AG is a building materials company listed on NYSE, reporting Q3 results and FY2026 guidance.

Company-level read

Ticker impact

$AMRZBearishHigh confidence
Context

Amrize AG reported Q3 earnings and issued full-year guidance below consensus, causing the stock to slide 6.9%.

Expected impact

downward pressure as investors price in weaker revenue guidance

Evidence & confidence

The guidance shortfall is material and the stock already fell; market will likely continue to sell on the news.

Market effects

Building materials sector may face pressure as cost inflation impacts margins.

North American construction markets could see tighter earnings forecasts.

Limited to investors tracking mid‑cap industrial stocks.

Counterpoint

If cost inflation stabilizes, the guidance miss may be temporary and the stock could rebound.

Key entities

  • Jan Jenisch

    Chairman and CEO of Amrize AG who commented on cost inflation.

Related articles

Med

Amrize Reports Third Quarter 2026 Results

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo

Med

A $1 billion share-buyback program is complete; Amrize returned $1.1 billion to shareholders

Amrize completed a $1 billion share-buyback program, returning $1.1 billion to shareholders. Q3 2026 revenue rose 2.2% to $3.77 billion, net income increased 3.3% to $558 million, and adjusted EBITDA grew 0.2% to $1.076 billion. The company updated FY 2026 guidance, citing cost inflation and higher interest rates. Amrize also declared a $0.11 per share dividend and completed the Rapid Redi-Mix acquisition in Dallas-Fort Worth.